SOUTHLAKE, Texas – ( BUSINESS WIRE ) – HeartSciences , a medical device company that is at the forefront of innovation in the field of electrocardiography thanks to the application of artificial intelligence and signal processing based on continuous waveforms (continuous wavelet transform, CWT), today announced the results of a clinical study conducted serially at The Icahn School of Medicine, Mount Sinai Hospital, New York, New York, and the Heart and Vascular Institute of West Virginia University (WVU), Morgantown, West Virginia.
The original text of this announcement, written in the source language, is the official version that is authentic. Translations are offered solely for the convenience of the reader and must refer to the original text, which is the only legally valid one.
Contacts
HeartSciences
Gene Gephart, + 1-737-346-1089
gene.gephart@heartsciences.com
or Investor
Contact
Zimmons International Communications
Jennifer K. Zimmons, + 1-917-214-3514
jzimmons@zimmonsic.com